Individualized Assessment and Treatment for Temporomandibular Joint Disorders
This study is testing two different approaches for treating Temporomandibular Joint Disorders (TMD), which cause jaw and facial pain. One approach is "Standard Conservative Care" plus a traditional "Cognitive-Behavioral Treatment" (CBT), which teaches coping skills. The other approach is "Standard Conservative Care" plus an "Individualized Assessment and Treatment Program" (IATP). The IATP uses a smartphone app to understand your pain experience in detail before treatment. Researchers want to see if the IATP leads to less pain, depression, and interference with daily activities compared to CBT. You may be able to join if you are over 18, have had jaw pain for more than 3 months, and meet specific diagnostic criteria for TMD. The study aims to enroll 160 participants, but its current status is unclear.
- Study design
- This study is an interventional trial involving 160 participants who will be randomly assigned to one of two treatment groups.
- What's involved
- You would participate in a 2-week monitoring period using a smartphone app before treatment. Your pain, daily activities, and depressive symptoms will be measured at the start, 7 weeks after treatment, and then at 3, 6, 9, and 12 months.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed for 12 months after treatment to assess changes in pain, daily activities, and depressive symptoms.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Individualized Assessment and Treatment for TMD
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Mark D Litt, PhD · PRINCIPAL_INVESTIGATOR · UConn Health
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Change in pain from baseline as measured by the 11-point Characteristic Pain Intensity Index at each follow-up pointBaseline and at the follow-up points 7 weeks (posttreatment), 3 months, 6 months, 9 months, and 12 months
Characteristic Pain Intensity will be calculated by averaging the ratings of current pain, average pain, and worst pain in the past week from the Graded Chronic Pain Scale (GCPS; Von Korff et al., 1992). Each item is scored from 0 -10.
- Change in interference with activities from Baseline as measured at all follow-up points by the 10-item Interference scale from the Multidimensional Pain Inventory (MPI; Kerns, Turk, & Rudy, 1985).Baseline and at the follow-up points: 7 weeks (posttreatment), 3 months, 6 months, 9 months, and 12 months
The MPI is a widely used, validated self-report inventory assessing various areas of impact by chronic pain. The Interference scale iconsists of 10 itmes assessing various areas of life that may have been affected or changed by chronic pain. Each item is scored from 0 to 6 (No change to Extreme Change).
- Change in Depressive Symptoms from baseline as measured by the 20-item Center for Epidemiological Studies Depression scale Revised (CESD-R) at each follow-up pointBaseline and at the follow-up points 7 weeks (posttreatment), 3 months, 6 months, 9 months, and 12 months
CESD-R is a 20-item scale assessing depressive symptoms. It was developed by the Center for Epidemiologic Studies (Radlof, 1977), and has shown high reliability and validity. The 20 items describe behaviors or feelings characteristic of depression that people may have. Respondents are instructed to indicate the extent they experience each item on a scale from Rarely to Most of the Time. The total score ranges from 0 to 80, with higher scores indicting mroe severe depressive symptomatology.